SNMMI Outreach Educational Tools

SNMMI Outreach Educational Tools



SNMMI Outreach Educational Tools

SNMMI's Outreach Committee has developed the following resources and tools to help equip members in their efforts to educate referring physicians and other appropriate audiences in their communities.

Enhancing Your Nuclear Medicine Practice
Nuclear Medicine Procedures Info Sheets
DETAIL Educational Slides
Amyloid/PET Resources
V/Q Scintigraphy Resources
Targeted Radionuclide Therapy Resources
Neuroendocrine Tumor Resources


(Please note: For best viewing results, please choose a browser other than Google Chrome.)

Enhancing Your Nuclear Medicine Practice

Outreach and Educational Tools to Enhance Your Nuclear Medicine Practice: A Professional and Practical Approach (June 2016; 80 minutes): Presentation by SNMMI Outreach Committee.


DETAIL Educational Slides

The Medical Imaging Technology Alliance has created this set of DETAIL (Demonstrating Excellence Through Advanced Imaging Learning) slides to promote education regarding the use of nuclear medicine in imaging and disease management:


Amyloid/PET Resources

Neuroimaging in Alzheimer's Disease (December 2015; 31 minutes): Presentation by Ilya Nasrallah, MD, PhD, University of Pennsylvania.


Appropriate use criteria for amyloid PET (Journal of Nuclear Medicine Article; January 28, 2013): The Amyloid Imaging Taskforce, created by the Alzheimer’s Association and the Society of Nuclear Medicine and Molecular Imaging, has developed a set of specific appropriate use criteria that define the types of patients and clinical circumstances in which amyloid PET could be used. Both appropriate and inappropriate uses are reported and discussed, as are future research directions.


V/Q Scintigraphy Resources

Optimized Use of V/Q in the Modern Era: Everything You Wanted to Know but Were Afraid to Ask (VOICE-Eligible Webinar; 53 minutes): This session presented at the Radiological Society of North America 2016 provides insights on V/Q scintigraphy in pulmonary embolism diagnosis, including how it can:

  • Provide comparable accuracy to computed tomography pulmonary angiography (CTPA)
  • Reduce radiation overexposure, particularly for women
  • Be used in a simple diagnostic algorithm to reduce overall radiation burden
  • Be interpreted using a scheme comparable to CTPA

Speakers: Alan Maurer, MD; Leonard M. Freeman, MD; Alan D. Waxman, MD.



Targeted Radionuclide Therapy Resources

Radiopharmaceutical Therapy Infographic: Offers an overview of radioisotope therapy and the relevant treatments for thyroid cancer, non-Hodgkins lymphoma, neuoroblastoma, liver cancer and liver-dominant metastatic disease, bone metastases from castration-resistant prostate cancer, and metastatic neuroendocrine tumors.


The Society held two joint programs at the 2016 Annual Meeting of the American Thyroid Association: 

I-131 for Distant Metastasis (58 minutes): Douglas Van Nostrand, MD, FACP, FACNM

 

Debate: Necessity of Radioactive Iodine Scans (46 minutes): Anca Avram, MD, and Martin Schlumberger, MD


The Society held a joint SNMMI/ASCO session on Targeted Radionuclide Therapy at the 2015 American Society of Clinical Oncology meeting. Presentations included the following videos: 

TRT in Prostate Cancer (26 minutes): Hossein Jadvar, MD, PhD, MPH, MBA, University of Southern California

 

Update on Radiopharmaceutical Treatment of Lymphoma (23 minutes): Richard L. Wahl, MD, Mallinckrodt Institute of Radiology at the Washington University School of St. Louis

 

TRT in Neuroendocrine Tumors (25 minutes): Alexander J. McEwan, MB, FRCPC, Chair, Department of Oncology, University of Alberta



Neuroendocrine Tumor Resources

The Society held a Symposium titled "New Approach in the Diagnosis and Management of Neuroendocrine Tumors" in Salt Lake City, Utah, in May 2017. Presentations included the following videos:

Introductory Remarks (6 minutes): Satoshi Minoshima, MD, PhD, University of Utah School of Medicine

 

A Patient's Perspective (16 minutes): Josh Mailman, NorCal Carcinet

 

Systemic Treatment of Neuroendocrine Tumors (26 minutes): Jonathan Whisenant, MD, University of Utah School of Medicine

 

Surgical Treatment of Pancreatic NET (14 minutes): Sean Mulvihill, MD, University of Utah

 

Surgical Treatment of Non-Pancreatic NET (20 minutes): Robert Glasgow, MD, University of Utah

 

New PET Imaging and Isotope Therapy of NET (30 minutes): Eric Mittra, MD, Stanford University

 

 

 

Resources for Your Patients

Fact Sheets: 23 fact sheets on nuclear medicine and molecular imaging (including many available now in Spanish).

DiscoverMI: SNMMI's patient-dedicated portal.

Request a Speaker

SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.

Outreach Speaker Request Form